Aton Ra Partners Axsome Therapeutics, Inc. Transaction History
Aton Ra Partners
- $50.1 Million
- Q4 2023
A detailed history of Aton Ra Partners transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 4,678 shares of AXSM stock, worth $424,434. This represents 0.74% of its overall portfolio holdings.
Number of Shares
4,678
Previous 5,180
9.69%
Holding current value
$424,434
Previous $362,000
2.76%
% of portfolio
0.74%
Previous 0.76%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
325Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$380 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$362 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$299 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$214 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$94.9 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.89B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...